GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telix Pharmaceuticals Ltd (OTCPK:TLPPF) » Definitions » PensionAndRetirementBenefit

Telix Pharmaceuticals (Telix Pharmaceuticals) PensionAndRetirementBenefit : $0.2 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Telix Pharmaceuticals PensionAndRetirementBenefit?

Telix Pharmaceuticals's PensionAndRetirementBenefit for the quarter that ended in Dec. 2023 was $0.2 Mil.

Telix Pharmaceuticals's quarterly PensionAndRetirementBenefit declined from Dec. 2022 ($0.1 Mil) to Jun. 2023 ($0.0 Mil) but then increased from Jun. 2023 ($0.0 Mil) to Dec. 2023 ($0.2 Mil).

Telix Pharmaceuticals's annual PensionAndRetirementBenefit increased from Dec. 2021 ($0.1 Mil) to Dec. 2022 ($0.1 Mil) and increased from Dec. 2022 ($0.1 Mil) to Dec. 2023 ($0.2 Mil).


Telix Pharmaceuticals PensionAndRetirementBenefit Historical Data

The historical data trend for Telix Pharmaceuticals's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telix Pharmaceuticals PensionAndRetirementBenefit Chart

Telix Pharmaceuticals Annual Data
Trend Sep99 Sep00 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PensionAndRetirementBenefit
Get a 7-Day Free Trial Premium Member Only - - 0.09 0.15 0.22

Telix Pharmaceuticals Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PensionAndRetirementBenefit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 - 0.15 - 0.22

Telix Pharmaceuticals PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Telix Pharmaceuticals (Telix Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
55 Flemington Road, Suite 401, North Melbourne, Melbourne, VIC, AUS, 3051
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.